Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Richard W. Rosenquist, MD, was appointed Chairman of the Department of Pain Management in the Anesthesiology Institute in July 2011. Dr. Rosenquist comes to Cleveland Clinic from the University of Iowa Hospitals and Clinics, where he served as Professor of Anesthesiology and Director of the Pain Medicine Division.
Dr. Rosenquist received his medical degree in 1984 from Northwestern University in Chicago, where he continued his residency training. He completed a fellowship in Regional Anesthesia/Pain and Critical Care at Grady Memorial Hospital/Emory University in Atlanta, Georgia, and joined the faculty there.
He returned to Chicago in 1990 as an Assistant Professor of Anesthesiology, Director, Acute Pain Control Service and Director, Center for Pain Management and Rehabilitation Medicine at the University of Illinois, College of Medicine before moving to Iowa in 1997.
Dr. Rosenquist is a Past-President of the American Society of Regional Anesthesia (ASRA) and has served on the ASRA Board of Directors. He currently is Chair of the American Society of Anesthesiologists (ASA) Committee on Pain Medicine and as a member of the ASA Committee on Economics. He also is Vice-Chair of the American Board of Anesthesiology (ABA) Pain Medicine Examination Committee.
Dr. Rosenquist’s areas of interest include myofascial pain, CRPS/RSD, neuropathic pain, cancer pain, sports-related pain, low back pain, acute postoperative pain, regional anesthesia and analgesia. His office phone number is 216.445.8388.
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 4/1/2014, Dr. Rosenquist has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.